Japan Vasculitis Drug Market Research Report 2018

April 2018 | 95 pages | ID: J0157A4D227EN
QYResearch

Abstracts

The global Vasculitis Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Vasculitis Drug development status and future trend in Japan, focuses on top players in Japan, also splits Vasculitis Drug by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Japan market include

• Merck
• Bayer
• Farmalider
• Hainan Pharmaceutical Factory
• Shanghaihuangxiang Lantian Pharmaceutical
• Huzhou Konch Pharmaceutical
• CSPC Ouyi Pharmaceutical
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical
• Hubei Biocause Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Blisibimod
• CCX-168
• Gevokizumab
• Rituximab Biosimilar
• Others

On the basis of the end users/Application, this report covers

• Polyarteritis Nodosa
• Thrombotic Vasculitis
• Granulomatous Vasculitis
• Lymphocytic Vasculitis
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Japan Vasculitis Drug Market Research Report 2018

1 VASCULITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Vasculitis Drug
1.2 Classification of Vasculitis Drug by Product Category
  1.2.1 Japan Vasculitis Drug Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 Japan Vasculitis Drug Sales (K Pcs) Market Share by Type in 2017
  1.2.3 Blisibimod
  1.2.4 CCX-168
  1.2.5 Gevokizumab
  1.2.6 Rituximab Biosimilar
  1.2.7 Others
1.3 Japan Vasculitis Drug Market by Application/End Users
  1.3.1 Japan Vasculitis Drug Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
  1.3.2 Polyarteritis Nodosa
  1.3.3 Thrombotic Vasculitis
  1.3.4 Granulomatous Vasculitis
  1.3.5 Lymphocytic Vasculitis
  1.3.6 Others
1.4 Japan Revenue and Sales of Vasculitis Drug (2013-2025)
  1.4.1 Japan Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.4.2 Japan Vasculitis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 JAPAN VASCULITIS DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Vasculitis Drug Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Japan Vasculitis Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Japan Vasculitis Drug Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Japan Vasculitis Drug Market Competitive Situation and Trends
  2.4.1 Japan Vasculitis Drug Market Concentration Rate
  2.4.2 Japan Vasculitis Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Vasculitis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 JAPAN VASCULITIS DRUG SALES AND REVENUE (VALUE) BY TYPE (2013-2018)

3.1 Japan Vasculitis Drug Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Japan Vasculitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Japan Vasculitis Drug Price (USD/Pcs) by Type (2013-2018)
3.4 Japan Vasculitis Drug Sales Growth Rate (%) by Type (2013-2018)

4 JAPAN VASCULITIS DRUG SALES BY APPLICATION (2013-2018)

4.1 Japan Vasculitis Drug Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Japan Vasculitis Drug Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 JAPAN VASCULITIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

5.1 Merck
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Vasculitis Drug Product Category, Application and Specification
    5.1.2.1 Product A
    5.1.2.2 Product B
  5.1.3 Merck Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.1.4 Main Business/Business Overview
5.2 Bayer
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Vasculitis Drug Product Category, Application and Specification
    5.2.2.1 Product A
    5.2.2.2 Product B
  5.2.3 Bayer Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.2.4 Main Business/Business Overview
5.3 Farmalider
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Vasculitis Drug Product Category, Application and Specification
    5.3.2.1 Product A
    5.3.2.2 Product B
  5.3.3 Farmalider Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.3.4 Main Business/Business Overview
5.4 Hainan Pharmaceutical Factory
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Vasculitis Drug Product Category, Application and Specification
    5.4.2.1 Product A
    5.4.2.2 Product B
  5.4.3 Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.4.4 Main Business/Business Overview
5.5 Shanghaihuangxiang Lantian Pharmaceutical
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Vasculitis Drug Product Category, Application and Specification
    5.5.2.1 Product A
    5.5.2.2 Product B
  5.5.3 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.5.4 Main Business/Business Overview
5.6 Huzhou Konch Pharmaceutical
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Vasculitis Drug Product Category, Application and Specification
    5.6.2.1 Product A
    5.6.2.2 Product B
  5.6.3 Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.6.4 Main Business/Business Overview
5.7 CSPC Ouyi Pharmaceutical
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Vasculitis Drug Product Category, Application and Specification
    5.7.2.1 Product A
    5.7.2.2 Product B
  5.7.3 CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.7.4 Main Business/Business Overview
5.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Vasculitis Drug Product Category, Application and Specification
    5.8.2.1 Product A
    5.8.2.2 Product B
  5.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.8.4 Main Business/Business Overview
5.9 Hubei Biocause Pharmaceutical
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Vasculitis Drug Product Category, Application and Specification
    5.9.2.1 Product A
    5.9.2.2 Product B
  5.9.3 Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.9.4 Main Business/Business Overview

6 VASCULITIS DRUG MANUFACTURING COST ANALYSIS

6.1 Vasculitis Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Vasculitis Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Vasculitis Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Vasculitis Drug Major Manufacturers in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN VASCULITIS DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

10.1 Japan Vasculitis Drug Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Japan Vasculitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Japan Vasculitis Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Japan Market Size (Million USD) Status and Outlook (2013-2025)
Table Vasculitis Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Vasculitis Drug Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Vasculitis Drug
Table Japan Vasculitis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Japan Vasculitis Drug Sales Volume Market Share by Type in 2017
Figure Blisibimod Product Picture
Figure CCX-168 Product Picture
Figure Gevokizumab Product Picture
Figure Rituximab Biosimilar Product Picture
Figure Others Product Picture
Figure Japan Vasculitis Drug Sales (K Pcs) Comparison by Application (2013-2025)
Figure Japan Sales Market Share (%) of Vasculitis Drug by Application in 2017
Figure Polyarteritis Nodosa Examples
Figure Thrombotic Vasculitis Examples
Figure Granulomatous Vasculitis Examples
Figure Lymphocytic Vasculitis Examples
Figure Others Examples
Figure Japan Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Japan Vasculitis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Japan Vasculitis Drug Sales of Key Players/Manufacturers (2013-2018)
Table Japan Vasculitis Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Vasculitis Drug Sales Share (%) by Players/Manufacturers
Figure 2017 Japan Vasculitis Drug Sales Share (%) by Players/Manufacturers
Table Japan Vasculitis Drug Revenue by Players/Manufacturers (2013-2018)
Table Japan Vasculitis Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Vasculitis Drug Revenue Share (%) by Players/Manufacturers
Figure 2017 Japan Vasculitis Drug Revenue Share (%) by Players/Manufacturers
Table Japan Market Vasculitis Drug Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Japan Market Vasculitis Drug Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Japan Vasculitis Drug Market Share of Top 3 Players/Manufacturers
Figure Japan Vasculitis Drug Market Share of Top 5 Players/Manufacturers
Table Japan Players/Manufacturers Vasculitis Drug Manufacturing Base Distribution and Sales Area
Table Japan Players/Manufacturers Vasculitis Drug Product Category
Table Japan Vasculitis Drug Sales (K Pcs) by Type (2013-2018)
Table Japan Vasculitis Drug Sales Share (%) by Type (2013-2018)
Figure Japan Vasculitis Drug Sales Share (%) by Type (2013-2018)
Figure Japan Vasculitis Drug Sales Market Share (%) by Type in 2017
Table Japan Vasculitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Japan Vasculitis Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Vasculitis Drug by Type (2013-2018)
Figure Revenue Market Share of Vasculitis Drug by Type in 2017
Table Japan Vasculitis Drug Price (USD/Pcs) by Type (2013-2018)
Figure Japan Vasculitis Drug Sales Growth Rate (%) by Type (2013-2018)
Table Japan Vasculitis Drug Sales (K Pcs) by Application (2013-2018)
Table Japan Vasculitis Drug Sales Market Share (%) by Application (2013-2018)
Figure Japan Vasculitis Drug Sales Market Share (%) by Application (2013-2018)
Figure Japan Vasculitis Drug Sales Market Share (%) by Application in 2017
Table Japan Vasculitis Drug Sales Growth Rate (%) by Application (2013-2018)
Figure Japan Vasculitis Drug Sales Growth Rate (%) by Application (2013-2018)
Table Merck Vasculitis Drug Basic Information List
Table Merck Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Merck Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Merck Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Merck Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Bayer Vasculitis Drug Basic Information List
Table Bayer Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bayer Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Bayer Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Bayer Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Farmalider Vasculitis Drug Basic Information List
Table Farmalider Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Farmalider Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Farmalider Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Farmalider Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Hainan Pharmaceutical Factory Vasculitis Drug Basic Information List
Table Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Basic Information List
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Huzhou Konch Pharmaceutical Vasculitis Drug Basic Information List
Table Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Basic Information List
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Basic Information List
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Hubei Biocause Pharmaceutical Vasculitis Drug Basic Information List
Table Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Sales Market Share (%) in Japan (2013-2018)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Revenue Market Share (%) in Japan (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vasculitis Drug
Figure Manufacturing Process Analysis of Vasculitis Drug
Figure Vasculitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Vasculitis Drug Major Players/Manufacturers in 2017
Table Major Buyers of Vasculitis Drug
Table Distributors/Traders List
Figure Japan Vasculitis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Japan Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Vasculitis Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table Japan Vasculitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Japan Vasculitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Japan Vasculitis Drug Sales Volume Market Share Forecast by Type in 2025
Table Japan Vasculitis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Japan Vasculitis Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure Japan Vasculitis Drug Sales Volume Market Share Forecast by Application in 2025